Personalised Primary Prevention Intervention for Vulnerable Informal Caregivers at Increased Risk of Cancer
NCT ID: NCT05310045
Last Updated: 2025-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
126 participants
OBSERVATIONAL
2022-04-04
2024-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Around 11 million of French citizens are informal caregivers, i.e. people who regularly and frequently provide a non-professional help to do all or part of daily life activities for a dependent person with a disability, disease, or due to age. In cancer, there are around 5 million of informal caregivers in France.
Studies have shown that informal caregivers of cancer patients are not only at risk for stress, anxiety, poor health, diminished quality of life, but also that they adopt so-called "risk behaviours" (e.g., increased smoking or alcohol consumption, unbalanced eating habits rich in fat, sugar and ultra-processed foods, sedentary lifestyle, etc.). These behaviours may develop or worsen co-morbidities and/or promote cancer development, outside hereditary context. Moreover, for certain types of cancer, related and unrelated family caregivers have a higher risk of developing cancer because they share the same lifestyle including the same risk factors. However, compared to general population, informal caregivers of cancer patients, have an increased risk perception and motivation to change a so-called unhealthy lifestyle.
In this context, our goal is to test the feasibility and acceptability of a personalised primary prevention intervention designed to informal caregivers of cancer patients at increased risk of cancer.
The intervention will be first designed to first-degree relatives and partners/spouses of a patient treated at Léon Bérard Center.
Developed in the Léon Bérard comprehensive cancer centre in close relation with outpatient care and based on an informal caregiver's tracking questionnaire, the intervention will be composed of two consultations with a physician trained in primary prevention and information and referral to health prevention structures.
As primary objectives, acceptability will be assessed based on informal caregivers' satisfaction and feasibility based on their participation rates.
As secondary objectives, informal caregivers' knowledge and risk perception will be assessed based on questionnaires and intention to change or change behaviour will be noted and analysed through individual semi-structured interviews.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cancer and Literacy in Health
NCT05008497
Impact of Sick Peer Relation on Adaptation to Disease and on Treatment of Cancer-suffering Adolescents & Young Adults
NCT03964116
A Sustainable Approach to Increasing Cancer Screening
NCT01395459
Implementing Personal Health Records to Promote Evidence-Based Cancer Screening
NCT02138448
Behavioral Intervention Study for Better Breast and Cervical Cancer Control for Korean American Women
NCT00857636
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Personalised primary prevention intervention
Personalised primary prevention intervention
1. Consultation 1
* Assess caregiver's situation regarding their cancer risk factors
* Explain the causal links between risk factors and cancer
* Inform about national recommendations to prevent and limit cancer risk
* Clarify informal caregiver situation with respect to national screening programs
* Define a personalised primary prevention program
2. Implementation: personalised primary prevention program
* Carried out by the informal caregiver
* Supervised by the coordinating nurse
3. Consultation 2
* Assess prevention actions realised by informal caregiver in relation to actions defined in the personalised primary prevention program
* Identify barriers and facilitators to their implementation whether actions or no actions have been done.
* Adapt the personalised primary prevention program to informal caregiver needs.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At increased risk of cancer
* Aged between 18 and 75 years;
* No diagnosis of genetic predisposition to cancer and no personal or informal history suggesting genetic predisposition;
* Able to complete a questionnaire in French, alone or with the help of a relative (persons with visual, mute, motor, hearing or intellectual disabilities will be included as long as they are able to complete a questionnaire alone or with the help of a relative);
* Being informed and not opposed to the study ;
* Having completed the entire tracking questionnaire and wishing to be contacted.
Exclusion Criteria
* Minor informal caregiver;
* Informal caregiver with a history of cancer;
* Patient under care at the Institute of Hematology and Pediatric Oncology;
* Individuals of legal age protected by law.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Leon Berard
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Béatrice FERVERS
Role: PRINCIPAL_INVESTIGATOR
Centre Léon Bérard (CLB)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Leon Berard
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PREV-AIDANT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.